Skip to content
Unrated Medical device recall · FDA · Published July 13, 2018

Tosoh G8 HPLC Analyzer Recall: Software Lacks 510K for Diabetic Testing

Tosoh recalls G8 HPLC analyzers with software missing a 510K clearance for hemoglobin A1c testing in diabetes diagnosis. Affected units have specific serial numbers listed.

🇺🇸 FDA recall #Z-3244-2018Medical deviceTosoh Biosc: Inc ›
Take action

Contact the company

Recalling firmTosoh Bioscience Inc3600 Gantz Rd · Grove City, OH 43123-1895
✎ GovInfoNow plain-language explainer

What happened, in plain English

Tosoh is recalling G8 Automated HPLC Analyzers that were sold with software lacking a required 510K clearance. This could affect the accuracy of hemoglobin A1c tests used for diabetes diagnosis. Affected units have specific serial numbers listed in the recall. Read more at govinfonow.com/recall/70606-tosoh-g8-hplc-analyzer-recall-software-lacks-510k-for-diabetic.

Source Summary by GovInfoNow · govinfonow.com/recall/70606-tosoh-g8-hplc-analyzer-recall-software-lacks-510k-for-diabetic · Updated August 20, 2026 · FDA enforcement record: FDA #Z-3244-2018

Cite this page

“Tosoh G8 HPLC Analyzer Recall: Software Lacks 510K for Diabetic Testing.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/70606-tosoh-g8-hplc-analyzer-recall-software-lacks-510k-for-diabetic. Based on FDA recall #Z-3244-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3244-2018%22&limit=1).

Why it’s dangerous

The software lacks a 510K clearance, which is a regulatory approval required for medical devices in the U.S. This could lead to inaccurate hemoglobin A1c results, potentially affecting diabetes diagnosis and treatment decisions.

Who’s affected

Healthcare providers using the G8 analyzers for hemoglobin A1c testing in diabetes diagnosis are likely affected. Patients relying on these tests for diabetes management may be at risk if the analyzer is used without proper software clearance.

How to tell if you have this one

Check if your G8 Automated HPLC Analyzer has serial numbers: 14646304, 14917201, 14886112, 14616503, 14856212, 14887601, 14886212, or 14917201. The device is used for hemoglobin A1c testing in diabetes diagnosis.

  • Brand
    Tosoh Biosc: Inc
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Serial Numbers

    Identify if your analyzer has one of the listed serial numbers: 14646304, 14917201, 14886112, 14616503, 14856212, 14887601, 14886212, or 14917201.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 4 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: named in the noticeWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide Distribution in states of - CA, OK, VA 7 WI” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: California, Oklahoma, Virginia, Wisconsin.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Jul 13, 201812. FDA classified it Class II: Sep 25, 201823. Published in FDA’s Enforcement Report: Oct 3, 201834. FDA terminated the recall: Jul 8, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3244-2018 (July 13, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3244-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA